Go to
JCI Insight
Citations to this article
Abstract
Risk stratification in prostate cancer remains a significant clinical challenge. A study in this issue of the JCI describes an exciting application of high-throughput functional genomic technology to further refine our understanding of treatment failure risk in prostate cancer patients .
Authors
James McKiernan, Mitchell C. Benson
Citation information
Citations to this article (1)
| Title and authors | Publication | Year |
|---|---|---|
|
Effects of platelet-activating factor and its differential regulation by androgens and steroid hormones in prostate cancers
Xu B, Gao L, Wang L, Tang G, He M, Yu Y, Ni X, Sun Y |
British Journal of Cancer | 2013 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)